A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 26
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PASE
Long Form : Psoriatic Arthritis Screening and Evaluation
No. Year Title Co-occurring Abbreviation
2019 Real-World Postmarketing Study of the Impact of Adalimumab Treatment on Work Productivity and Activity Impairment in Patients with Psoriatic Arthritis. ACR, BASDAI, CASPAR, HAQ-DI, OWI, PASI, PsA, WPAI
2018 Gastrointestinal Signs and Symptoms Related to Inflammatory Bowel Disease in Patients With Moderate-to-Severe Psoriasis GI, IBD, PsA, PsO
2018 Semantic and psychometric validation of the Brazilian Portuguese version (PASE-P) of the Psoriatic Arthritis Screening and Evaluation questionnaire. ---
2017 Comparison of four validated psoriatic arthritis screening tools in diagnosing psoriatic arthritis in patients with psoriasis (COMPAQ Study). EARP, PASE 44, PEST, PsA, ToPAS II
2017 Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies. CASPAR, CPDAI, DAPSA, DMARDs, EULAR, GRAPPA, JAK, PASQ, PEST, PsA, PsAJAI, TOPAS
2017 Performance of screening tools for psoriatic arthritis: a cross-sectional study in primary care. EARP, PEST
2017 The STRIPP questionnaire (Screening Tool for Rheumatologic Investigation in Psoriatic Patients) as a new tool for the diagnosis of early psoriatic arthritis. PsA, STRIPP
2016 Clinical features of psoriatic arthritis in Korean patients with psoriasis: a cross-sectional observational study of 196 patients with psoriasis using psoriatic arthritis screening questionnaires. PEST, PsA
2016 PASE and EARP questionnaires for the identification of enthesitis, synovitis, and tenosynovitis in patients with psoriasis. EARP, ROC
10  2016 Validation and Field Performance of the Italian Version of the Psoriatic Arthritis Screening and Evaluation (PASE) Questionnaire. PsA, ROC
11  2015 Alcohol intake and risk of incident psoriatic arthritis in women. PsA
12  2015 Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice. ---
13  2015 Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool. CASPAR, PsA
14  2015 Screening for Psoriatic Arthritis in Korean Psoriasis Patients Using the Psoriatic Arthritis Screening Evaluation Questionnaire. PsA
15  2014 Remission criteria and activity indices in psoriatic arthritis. ACR/EULAR, CDAI, CI, CPDAI, DAPSA, DAS28, PsA, RA, SDAI
16  2014 Turkish PASE: Turkish Version of the Psoriatic Arthritis Screening and Evaluation Questionnaire. PsA
17  2014 Utility of the PASE questionnaire, psoriatic arthritis (PsA) prevalence and PsA improvement with anti-TNF therapy: results from the PRISTINE trial. PsA
18  2013 Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). PEST, PsA, ROC, ToPAS
19  2013 High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. PEST, Ps, PsA, ToPAS
20  2013 Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis. PEST, PsA, ToPAS
21  2012 The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis. EARP, ePsA
22  2011 Clinical symptoms of skin, nails, and joints manifest independently in patients with concomitant psoriasis and psoriatic arthritis. JA, LS-PGA, NA, PsA, PsAA, PsO, PWESI
23  2011 Psoriasis Epidemiology Screening Tool (PEST): a report from the GRAPPA 2009 annual meeting. PEST, PsA
24  2011 Psoriatic Arthritis Screening and Evaluation (PASE) questionnaire and the role of dermatologists: a report from the GRAPPA 2009 annual meeting. GRAPPA, PsA
25  2011 Toronto Psoriatic Arthritis Screening (ToPAS) questionnaire: a report from the GRAPPA 2009 annual meeting. PsA, ToPAS, ToPAS
26  2009 Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. PsA